Table 1.
Summary of MSCs clinical trials in BPD.
| Phase | Design | Number of Participants (Expected or Final) | Cell Origin | NCT ID |
|---|---|---|---|---|
| I | Open | 10 | MSCs (not specified) | NCT02443961 |
| I, II | Open | 12 | HUCB-MSCs | NCT02381366 |
| I | Randomized, placebo-controlled, double-blind | 10 | HUC-MSCs | NCT01207869 |
| I | Open | 9 | HUCB-MSCs | NCT01297205 |
| II | Randomized, placebo-controlled, double-blind | 70 | HUCB-MSCs | NCT01828957 |
| II | Randomized, placebo-controlled double-blind | 70 | HUCB-MSCs | NCT01897987 |
| I | Open, observational | 9 | HUCB-MSCs | NCT01632475 |
| I | Open, observational (2 year follow up from study NCT01632475) |
9 | HUCB-MSCs | NCT02023788 |
HUCB-MSCs: human umbilical cord blood derived MSCs.
HUC-MSCs: human umbilical cord derived MSCs.